INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Open letter to Ms. Emer Cooke, Executive Director, European Medicines Agency (EMA)

Open letter to Ms. Emer Cooke, Executive Director, European Medicines Agency (EMA)

GMDP in relation to COVID-19 vaccines that are delivered to vaccination centres bypassing the wholesaler networks

Hedley Rees's avatar
Hedley Rees
Jan 22, 2025
∙ Paid
18

Share this post

INSIDE PHARMA
INSIDE PHARMA
Open letter to Ms. Emer Cooke, Executive Director, European Medicines Agency (EMA)
11
7
Share

This has been on the PharmaFlow Web site since June 2024

Open letter to Ms. Emer Cooke, Executive Director, European Medicines Agency (EMA)

To save you having to click the link (although there is a picture of a pretty lady on there), this is the text:

Dear Ms. Cooke,

This is an open letter in relation to a question I submitted via EMAs: Send a question to the European Medicines Agency, on 20/12/2020. This is EMAs acknowledgement of the question:

“We received your question(s) on: 20/12/2020

Subject of your enquiry: GMDP in relation to COVID-19 vaccines that are delivered to vaccination centres bypassing the wholesaler networks

Your question(s):
Dear EMA,

I am an experienced consultant in biopharmaceutical supply- chains. I wish to enquire how the inspectorate with assure GMDP and appropriate quality systems will be maintained with regard to patient safety for the frozen and ultra cold vaccines being assessed for emergency approval? It appears to me that these vaccines are being despatched from …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share